Page last updated: 2024-08-24

triazoles and Breast Cancer, Male

triazoles has been researched along with Breast Cancer, Male in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (57.14)	29.6817
2010's	6 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dalmau, E; Fernández-Morales, LA; Marín, M; Martinez Vila, C; Oliveres, H; Pardo, JC; Ribera, P; Segui, MA	1
Barba, M; Del Medico, P; Di Lauro, L; Giannarelli, D; Laudadio, L; Maugeri-Saccà, M; Pizzuti, L; Sergi, D; Tomao, S; Vici, P	1
Dakhil, SR; Hines, SL; Kearns, AE; Lafky, JM; Liu, H; Loprinzi, CL; Perez, EA; Puttabasavaiah, S; Sloan, JA; Wagner-Johnston, ND	1
An, HJ; Byun, JH; Chung, SM; Ha, KS; Hong, JH; Jung, SS; Jung, YH; Kang, D; Kim, JS; Lee, GJ; Park, IY; Park, JC; Park, S; Park, WC; Suh, YJ; Won, HS; Woo, IS	1
Doyen, J; Ferrero, JM; Fontana, X; Italiano, A; Largillier, R; Thyss, A	1
Beyer, A; Cai, WY; Elledge, R; Fuqua, S; Hilsenbeck, S; Huang, J; Massarweh, S; Rimawi, M; Sexton, K; Tham, YL; Tsimelzon, A; Weiss, H	1
Ferrero, JM; Foa, C; Hartmann, MT; Italiano, A; Largillier, R; Marcy, PY; Namer, M	1
Meterissian, SH; Zabolotny, BP; Zalai, CV	1
Alba, E; Barnadas, A; Carabante, F; Colomer, R; Fernández, R; Gil, M; González, J; Llombart, A; Mayordomo, JI; Palomero, I; Ramos, M; Ribelles, N; Ruiz, M; Soriano, V; Tusquets, I; Vera, R	1
Giordano, SH; Hortobagyi, GN	1
Carmona-Bayonas, A	1
Arriola, E; Dowsett, M; Hui, E; Smith, IE	1
Pritchard, KI; Seong Ooi, W; Soon Wong, N	1
Buzdar, AU; Giordano, SH; Hortobagyi, GN; Valero, V	1

Reviews

1 review(s) available for triazoles and Breast Cancer, Male

Article	Year
Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer. Journal of surgical oncology, 2005, Apr-01, Volume: 90, Issue:1 Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Humans; Letrozole; Male; Nitriles; Triazoles	2005

Trials

2 trial(s) available for triazoles and Breast Cancer, Male

Article	Year
5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial. Cancer, 2015, Aug-01, Volume: 121, Issue:15 Topics: Aged; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Diphosphonates; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imidazoles; Letrozole; Male; Middle Aged; Nitriles; Osteoporosis, Postmenopausal; Postmenopause; Tamoxifen; Triazoles; Zoledronic Acid	2015
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer. Breast cancer research and treatment, 2011, Volume: 129, Issue:3 Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Cell Cycle; Cyclin D1; Estradiol; Female; Fulvestrant; Gefitinib; Humans; Ki-67 Antigen; Male; Mitogen-Activated Protein Kinases; Neoadjuvant Therapy; Nitriles; Oncogene Protein v-akt; Proto-Oncogene Proteins; Quinazolines; Receptors, Estrogen; Receptors, Progesterone; Triazoles	2011

Article

Year

5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.

Cancer, 2015, Aug-01, Volume: 121, Issue:15

Topics: Aged; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Diphosphonates; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imidazoles; Letrozole; Male; Middle Aged; Nitriles; Osteoporosis, Postmenopausal; Postmenopause; Tamoxifen; Triazoles; Zoledronic Acid

2015

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.

Breast cancer research and treatment, 2011, Volume: 129, Issue:3

Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Cell Cycle; Cyclin D1; Estradiol; Female; Fulvestrant; Gefitinib; Humans; Ki-67 Antigen; Male; Mitogen-Activated Protein Kinases; Neoadjuvant Therapy; Nitriles; Oncogene Protein v-akt; Proto-Oncogene Proteins; Quinazolines; Receptors, Estrogen; Receptors, Progesterone; Triazoles

2011

Other Studies

11 other study(ies) available for triazoles and Breast Cancer, Male

Article	Year
Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 08-01, Volume: 28, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Estradiol; Fulvestrant; Gonadotropin-Releasing Hormone; Humans; Letrozole; Male; Neoplasms, Multiple Primary; Nitriles; Prostatic Neoplasms; Tamoxifen; Triazoles	2017
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer. Breast cancer research and treatment, 2013, Volume: 141, Issue:1 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Estrogen Receptor Modulators; Estrogens; Fluorouracil; Gonadotropin-Releasing Hormone; Goserelin; Humans; Kaplan-Meier Estimate; Letrozole; Male; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Progesterone; Radiotherapy, Adjuvant; Tamoxifen; Taxoids; Triazoles	2013
Clinical Features of Male Breast Cancer: Experiences from Seven Institutions Over 20 Years. Cancer research and treatment, 2016, Volume: 48, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Female; Hormone Replacement Therapy; Humans; Letrozole; Male; Mastectomy; Middle Aged; Neoplasms, Second Primary; Nitriles; Prognosis; Receptor, ErbB-2; Republic of Korea; Tamoxifen; Trastuzumab; Treatment Outcome; Triazoles	2016
Aromatase inhibition in male breast cancer patients: biological and clinical implications. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma; Estradiol; Humans; Letrozole; Male; Middle Aged; Neoplasm Metastasis; Nitriles; Retrospective Studies; Survival Analysis; Testosterone; Treatment Outcome; Triazoles	2010
[Complete remission obtained with letrozole in a man with metastatic breast cancer]. La Revue de medecine interne, 2004, Volume: 25, Issue:4 Topics: Aged; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms, Male; Humans; Letrozole; Male; Neoplasm Metastasis; Nitriles; Remission Induction; Treatment Outcome; Triazoles	2004
Serum endostatin and bFGF as predictive factors in advanced breast cancer patients treated with letrozole. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Breast Neoplasms, Male; Disease Progression; Endostatins; Female; Fibroblast Growth Factor 2; Humans; Letrozole; Male; Middle Aged; Nitriles; Predictive Value of Tests; Prospective Studies; Triazoles	2006
Leuprolide acetate plus aromatase inhibition for male breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jul-20, Volume: 24, Issue:21 Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Humans; Letrozole; Leuprolide; Lung Neoplasms; Lymphatic Metastasis; Male; Mastectomy, Modified Radical; Middle Aged; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome; Triazoles	2006
Potential benefit of maintenance trastuzumab and anastrozole therapy in male advanced breast cancer. Breast (Edinburgh, Scotland), 2007, Volume: 16, Issue:3 Topics: Adult; Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms, Male; Humans; Male; Nitriles; Receptor, ErbB-2; Receptors, Estrogen; Trastuzumab; Triazoles	2007
Aromatase inhibitors and male breast cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2007, Volume: 9, Issue:3 Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyproterone Acetate; Estradiol; Estrogens; Estrogens, Conjugated (USP); Humans; Letrozole; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Phobic Disorders; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Spinal Neoplasms; Testosterone; Treatment Outcome; Triazoles	2007
Role of gonadotropin-releasing hormone analog in the management of male metastatic breast cancer is uncertain. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Aug-20, Volume: 25, Issue:24 Topics: Androgens; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms, Male; Goserelin; Humans; Letrozole; Lung Neoplasms; Male; Middle Aged; Nitriles; Triazoles	2007
Efficacy of anastrozole in male breast cancer. American journal of clinical oncology, 2002, Volume: 25, Issue:3 Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms, Male; Combined Modality Therapy; Enzyme Inhibitors; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nitriles; Treatment Failure; Triazoles	2002